Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 2
Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,309 | Dovepress* | 6,309+ | 2,229 | 8,538 | |
Totals | 6,309 | 2,229 | 8,538 | ||
*Since 15 May 2007 +Since July 2016 |
View citations on Google Scholar